期刊文献+

几种肿瘤转移基因变化与卵巢癌转移的相关性 被引量:4

Alteration of Multiple Tumor Metastatic Genes with Correlation to Metastasis in Ovarian Carcinoma
下载PDF
导出
摘要 目的 研究 MTA1、nm2 3H1 及 E- Cadherin(E- cad)的表达及突变与卵巢癌转移的相关性。方法 应用 RT- PCR、RT- PCR- SSCP和免疫组化技术 ,对正常卵巢、卵巢癌及其配对淋巴结组织进行 MTA1、nm2 3H1m RNA表达和突变及 E- cad蛋白表达的检测。结果 有转移的卵巢癌原发灶 MTA1m RNA高表达率为 10 0 % (7/7) ,无转移为 38.5 % (5 / 13) ,P=0 .0 10 3。有癌转移淋巴结高表达率为 87.5 % (6 / 7) ,而无癌转移为 2 3% (3/ 13) ,P=0 .0 118。有转移卵巢癌原发灶 nm2 3H1 m RNA低表达率为 10 0 % (7/ 7) ,无转移为 30 % (4/ 13) ,P=0 .0 0 43。有癌转移淋巴结低表达率为 10 0 % (7/ 7) ,无癌转移为 38.5 % (5 / 13) ,P=0 .0 10 2。无转移卵巢癌原发灶 E- cad蛋白表达阳性率为 46 .2 % (6 / 13) ,而有转移者 7例均无阳性表达 ,表达率为 0 ,P=0 .0 44。三基因表达相关性分析表明 ,MTA1与 nm2 3H1 、C- cad呈负相关 (r=- 0 .90 3、- 0 .80 2 ) ,nm2 3H1 与 E- cad呈正相关 (r=0 .72 4)。SSCP分析未发现 MTA1和 nm2 3H1 基因突变。结论  MTA1及 nm2 3H1 、E- cad的表达与卵巢癌转移呈正、负相关关系 ,起着正、负调控的重要作用。 Objective To investigate the expression and mutation of MTA1? nm23H 1 and E cadherin(E cad) genes in ovarian carcinoma (OC) in relation to lymph node (LN) metastasis. Methods A panel of normal ovarian tissues, primary OC specimens and corresponding LNS was examined for mRNA expression and mutation of MTA1 and nm23H 1 and protin expression of E cad genes by using RT PCR, RT PCR SSCP and immunohistochemistry. Results The frequency of MTA1 over expression was 100%(7/7)in primary OC with metastasis but only 38.5%(5/13) in those without metastasis( P =0.0103). Overexpression of MTA1 was observed in 87.5%(6/7) of LNS with metastasis but in only 23%(3/13) of LNS without metastasis ( P =0.0118). In contrast with MTA1, low expression of nm23H 1 mRNA was seen in 7 of 7 OC with metastasis but only in 4 of 13(30%) of those without metastasis ( P =0.0043). Low nm23H1 expression was also seen in 7 of 7 LNS with metastasis but only in 5 of 13(38.5%) nonmetastatic LNS ( P =0.0102).Meantime, no expression of E cad protein was observed in 7 of 7 OC with metastasis but in 6 of 13(46.2%)of those without metastasis ( P =0.044). In correlation analysis of the three genes, MTA1 reversely correlated with nm23H 1 and E cad respectively ( r = -0 903, -0.803), and positive correlation existed between nm23H 1 and E cad (r=0.724).No mutation of MTA1, nm23H 1 and was found by SSCP analysis. Conclusion The mRNA expression of MTA1, nm23H 1 and E cad is positively and negatively correlated with LN metastasis. The expression abnormalities but not the mutations of the three genes are frequent events related to LN metastasis of ovarian cancer.
出处 《华西医科大学学报》 CSCD 北大核心 2002年第1期28-31,34,共5页 Journal of West China University of Medical Sciences
关键词 卵巢癌 淋巴结转移 MTA1基因 NM23H1基因 E-钙粘蛋白基因 基因表达 基因突变 肿瘤转移 Ovarian carcinoma Lymphnode metastasis MTA1 gene nm23H 1 gene E cadherin gene Gene expression and mutation
  • 相关文献

参考文献10

  • 1[1]Sawan A. Lascul, Veron M, et al. NDPK/nm23 expressi on in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohisto-chemical study. J Pathology, 1994; 172 (1):27
  • 2[2]Shiozaki H, Tahara H, Oka H, et al. Expression of immunoreact ive E-cadherin adhesion molecules in human cancer. Am J Pathol, 1991; 139 (1): 17
  • 3[3]Toh Y, Pencil SD, Nicolson GL, A Novel cndidate metastasis-assoc iated gene, mtal, differentially expressed in high metastatic mammary adenocarci noma cell line. J Biological Chemistry, 1994; 269(37):22958
  • 4[4]Toh Y, oki E, Ods S, et al. Overexpressionof MTA1 gene in ga strointestinal carcinoma: correlation with invasion and metastasis. Int J Cancer , 1997; 74(4):459
  • 5[5]Toh Y, Kiwano H, Mori M, et al. Overexpression of met astasis -associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer, 1999; 79 (11-12): 1723
  • 6[6]Tokunaga Y, Urano T, Furukawa K, et al. Reduced expre ssion of nm23H1 but not of nm23H2, is concordant with the freguency of lymph-node m etastasis of human breast cancer. Int J Cancer, 1993; 55(3):66
  • 7[7]Berx G, Staes K, Van Hengel J, et al. Cloning and cha racterzi tion of the human invasion suppressor gene E-cadherin(CDHI). Genomics, 1995; 26 :(2)281
  • 8[8]Toh Y, Kuninaka S, Endo K, et al Molecular analysis o f a cand idate metastasis-associated, MTA1: possible inferaction with histone deacetylas e 1. J Exp Clin Cancer Res, 2000;19(1):105
  • 9[9]Lakshmi MS, Parker C, Sherbet GV .Metastasis associated m tsl and nm23 gene affect tubulin polymerization II in B16 melanomas: a possible mechanis m of their regulation of metastasis behaviour of tumors. Anticancer Res, 1993; 1 3(2):299
  • 10[10]Shapiro L, Fannon AM, Kwong PD, et al. Structural base of ce ll-adhesion by cadherin. Nature.,1995;374(23):327

同被引文献41

  • 1韩秋峪,张向宁,李晓翠,曹丽.KAI1/CD82和E-Cadherin蛋白在卵巢上皮性癌中表达的临床意义[J].山东大学学报(医学版),2006,44(7):729-733. 被引量:5
  • 2Toh Y, Kunimaka S, Endo K, et al. Molecular analysis of a candidate metastesis-associated, MTA1: possible inferaction with histone deacy case. J Exp Clin Cancer Res, 2000,19 (1):105.
  • 3Nawa A, Nishimori K,Lin P,et al. Tumor metastasis-associated human MTA1 gene :its deduced protein sequence,localization and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem, 2000, 79 (2) :202.
  • 4Cautrecasas M, Erill N,Musulen E,et al. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinico-pathologic study of 144 patients. Cancer, 1998,82(6) :1088~1095.
  • 5Zeimet AG, Widschwendte M, Uhl SM ,et al. High serum levels of soluble CD44 variant isoform are associated with favourable clinical outcome in ovarian cancer. BR J Cancer, 1997,76(12):1646.
  • 6Nagfuchi A,Takei M. Cell binding function of E-cad is regulated by the cytoplastic domain. Embo J, 1998,7: 3679~ 3684.
  • 7Christopher D, Xiao Yu D, Julie F, et al. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovrian cancer progression. Gynecol Oncol, 2002,86: 69~78.
  • 8Schindl M, Birner P, Breitenecker G, et al. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer [ J ]. Gynecol Oncol,2001, 83(2) :244 -248.
  • 9Houle CD, Ding XY, Foley JF, et al. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression [ J ]. Gynecol Oncol, 2002,86 (1) :69 -78.
  • 10Liebermann DA, Haffman B, Steinman RA, et al. Molecular controis of growth arrest and apoptosis, p53 - dependent and independent pathways [ J]. Oncogene, 1998,11 ( 7 ) : 199 - 209.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部